Payer Almanac
About the data Sign in
Revenue & risk scoresPart D resultsMedical loss ratioWhere the money goesPremiums & MOOPBenefitsACOs

Part D results

CMS's year-end Part D reconciliation, 2022–2024. When a plan's actual drug costs land well above its bid, CMS shares the loss through risk sharing (the "risk corridors"); when they land well below, the plan pays CMS back. A large positive amount means the plan's drug bid was badly underpriced. 2024 is the latest year CMS has published.

$3.6B
net risk sharing paid to plans, 2024 · 571 contracts paid, 348 paid back
$416M
net risk sharing paid to plans, 2023 · 433 contracts paid, 495 paid back
$987M
net risk sharing paid to plans, 2022 · 406 contracts paid, 480 paid back
How to read this

Risk sharing: positive = CMS paid the plan (costs ran over the bid by more than the corridor); negative = the plan paid CMS. These are CMS's settled figures. Plans also report risk sharing in their MLR filings, sometimes as an estimate made before CMS settled, so a filing can differ.

Per member per year: risk sharing ÷ Part D member-months × 12. Part D member-months include stand-alone drug plan (PDP) members.

CMS's reconciliation also settles reinsurance (catastrophic drug costs) and low-income cost sharing; those are pass-through subsidies, not a sign of profit or loss, so they're shown on contract pages only.

Parent: MHH Healthcare, L.P. ×
202420232022 3-year total Per member per year2024 Part D members2024 avg
H5577 MCS Classicare $8.6M$5.2M$12.1M $25.9M $31 274,408
H3706 GlobalHealth $1.2M−$93.5K$674K $1.8M $87 13,954
H6062 GlobalHealth —−$32.4K— −$32.4K — —

Red = CMS paid the plan. Sorted by the 3-year total. Parent totals add up each contract under its current parent; CMS also publishes its own parent rollup, which can differ where contracts changed hands.